103 related articles for article (PubMed ID: 16050163)
1. Perspectives on compensated plasma donation.
Bult JM
Dev Biol (Basel); 2005; 120():113-7. PubMed ID: 16050163
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of paid whole and plasma donation.
Kretschmer V; Weippert-Kretschmer M; Slonka J; Karger R; Zeiler T
Dev Biol (Basel); 2005; 120():101-11. PubMed ID: 16050162
[TBL] [Abstract][Full Text] [Related]
3. Payment, compensation and replacement--the ethics and motivation of blood and plasma donation.
Farrugia A; Penrod J; Bult JM
Vox Sang; 2010 Oct; 99(3):202-11. PubMed ID: 20576023
[TBL] [Abstract][Full Text] [Related]
4. [That's why new blood donation guidelines are needed. The National Board of Health and Welfare introduces a 1-year waiting period for blood donors with risky sexual behavior].
Tegnell A; Printz A; Axelsson M
Lakartidningen; 2010 Feb 24-Mar 2; 107(8):488-9. PubMed ID: 20384056
[No Abstract] [Full Text] [Related]
5. China is urged to compensate people infected with HIV through illegal blood selling.
Parry J
BMJ; 2012 Mar; 344():e1740. PubMed ID: 22403266
[No Abstract] [Full Text] [Related]
6. Retention of prospective donors: a survey about services at a blood donation centre.
Moog R
Transfus Apher Sci; 2009 Jun; 40(3):149-52. PubMed ID: 19362518
[TBL] [Abstract][Full Text] [Related]
7. Errors and Omissions: Donor Compensation Policies and Richard Titmuss.
Penrod J; Farrugia A
HEC Forum; 2015 Dec; 27(4):319-30. PubMed ID: 25680344
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
9. Transfusion medicine in the 1990s, why it has changed and how.
Pittman DL; Phillips MR
Mo Med; 1992 Nov; 89(11):785-9. PubMed ID: 1291866
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of prospective donors: what do they expect from a homepage of a blood transfusion service?
Moog R; Fourné K
Transfus Med; 2007 Aug; 17(4):279-84. PubMed ID: 17680953
[TBL] [Abstract][Full Text] [Related]
11. Voluntary whole-blood donors, and compensated platelet donors and plasma donors: motivation to donate, altruism and aggression.
Trimmel M; Lattacher H; Janda M
Transfus Apher Sci; 2005 Oct; 33(2):147-55. PubMed ID: 16115800
[TBL] [Abstract][Full Text] [Related]
12. Movement toward international harmonisation. Activities of the WHO, GCBS and Council of Europe.
Koistinen J
Dev Biol (Basel); 2005; 120():157-63. PubMed ID: 16050169
[TBL] [Abstract][Full Text] [Related]
13. Ethical issues in transfusion medicine: the safety of blood and hematopoietic stem cell donation.
Domen RE
Curr Hematol Rep; 2005 Nov; 4(6):465-9. PubMed ID: 16232384
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of soluble inflammatory mediators between blood donation and pre-storage leucocyte depletion.
Chudziak D; Sireis W; Pfeiffer HU; Henschler R; Seifried E; Bönig H
Vox Sang; 2009 Feb; 96(2):163-6. PubMed ID: 19152610
[TBL] [Abstract][Full Text] [Related]
15. Donor management in South-East Asia region (SEAR).
Bharucha ZS
Dev Biol (Basel); 2005; 120():145-53. PubMed ID: 16050168
[TBL] [Abstract][Full Text] [Related]
16. What would encourage blood donation in Ireland?
Harrington M; Sweeney MR; Bailie K; Morris K; Kennedy A; Boilson A; O'Riordan J; Staines A
Vox Sang; 2007 May; 92(4):361-7. PubMed ID: 17456160
[TBL] [Abstract][Full Text] [Related]
17. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C compensation may be extended.
Comeau P
CMAJ; 2005 Jan; 172(1):25. PubMed ID: 15632397
[No Abstract] [Full Text] [Related]
19. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
Diro E; Alemu S; G/Yohannes A
Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
[TBL] [Abstract][Full Text] [Related]
20. The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors.
Inci Fisenk B; Us D; Ozcebe OI; Hascelik G
Scand J Infect Dis; 2005; 37(8):599-604. PubMed ID: 16099770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
